This study thoroughly evaluated the high methylation status of the CCND2 promoter region in UCEC tissues and the significantly reduced mRNA expression level, which was considered an early event in tumor occurrence and may serve as a potential biomarker for early diagnosis of UCEC. This evidence concerns the gene CCND2 and neoplasm.